Breaks Categories: News

MondayNov 04, 2019 10:58 am

NetworkNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) Issues Lung Cancer Prevention Measures in Support of Lung Cancer Awareness Month

Clinical-stage gene therapy company Genprex (NASDAQ: GNPX) today announced that it is publishing lung cancer prevention measures in an effort to educate the public, prevent new cases and raise awareness in support of November’s Lung Cancer Awareness Month. According to the update, each case is unique, but several preventative actions may lower the risk of lung cancer, including avoiding or quitting smoking, reducing exposure to secondhand smoke and radon, and knowing one’s familial history with lung cancer. Genprex is developing potentially life-changing technologies for cancer patients, based upon a unique proprietary technology platform, including its initial product candidate, Oncoprex(TM) immunogene…

Continue Reading

MondayNov 04, 2019 10:34 am

NetworkNewsBreaks – Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) Bolsters Digital Sales & Marketing Expertise with Board Appointment of E-Commerce Senior Executive Jill Braff

Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF), a leading cannabis branded products company in the U.S., today announced the addition of Brit + Co President Jill Braff to its board of directors. According to the update, Braff brings decades of experience in marketing and e-commerce through serving in various leadership roles for a number of well-known companies, including HSN, Ellen (DeGeneres) Digital Ventures, Ancestry.com, and, most recently, Brit + Co. Braff has received numerous awards and recognitions throughout her career, including being named one of the 40 Most Influential People Under 40 by Silicon Valley Business Journal and one of…

Continue Reading

MondayNov 04, 2019 9:52 am

NetworkNewsBreaks – CloudCommerce, Inc. (CLWD) Benefiting from Dramatic Transition to Digital Advertising

CloudCommerce (OTCQB: CLWD), a leading provider of advanced digital marketing solutions, on Friday announced that it is benefiting from the dramatic transition in the U.S. from traditional to digital advertising. Per the update, and according to eMarketer’s latest forecast, this year, for the first time, digital advertising spending in the U.S. will be greater than traditional advertising spending. By 2023, digital advertising is expected to exceed two-thirds of total media spending. “CloudCommerce has benefited greatly from this transition to digital advertising,” CLWD CEO Andrew Van Noy said in the news release. “Digital marketing is our strength and the reason we…

Continue Reading

FridayNov 01, 2019 11:39 am

NetworkNewsBreaks – Soleno Therapeutics, Inc. (NASDAQ: SLNO) Secures $15.4 Million in Underwritten Public Offering

Soleno Therapeutics (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, has closed an underwritten public offering of 12,841,667 of its common stock shares, which includes 1,675,000 additional shares per the full exercise of the over-allotment option granted to the underwriters. According to the update, the offering resulted in gross proceeds of approximately $15.4 million to Soleno, with each of the shares sold at the public offering price of $1.20. Soleno intends to use the offering proceeds primarily for working capital and general corporate purposes. ROTH Capital Partners acted as co-manager for the offering.…

Continue Reading

FridayNov 01, 2019 10:00 am

NetworkNewsBreaks – Reed’s Inc. (NASDAQ: REED) Secures $7 Million in Underwritten Public Offering

Reed’s Inc. (NASDAQ: REED), owner of the nation’s leading portfolio of handcrafted, all-natural beverages, has closed an underwritten public offering of 11,666,667 shares of its common stock. According to the update, the offering resulted in approximately $7 million of gross proceeds to Reed’s Inc., with each of the shares sold at the public offering price of $0.60. Reed’s intends to use the offering’s proceeds to fund the growth of its business, new products, sales and marketing efforts, working capital, and for general corporate purposes. In addition, Reed’s has granted a 45-day option to the underwriter to purchase up to an…

Continue Reading

FridayNov 01, 2019 9:45 am

NetworkNewsBreaks – Endonovo Therapeutics Inc. (ENDV) Announces Reverse Stock Split

Endonovo Therapeutics (OTCQB: ENDV), a commercial-stage developer of noninvasive Electroceutical(R) therapeutic devices, on Thursday announced its filing of a preliminary information statement with respect to a proposed reverse stock split of its common stock at a ratio of between 1 for 100 and 1-for-1,000. According to the update, the proposed reverse stock split effectiveness is contingent upon final SEC clearance of the Information Statement, mailing of the statement and a twenty-day waiting period, Endonovo’s sole director’s decision as to the final ratio of the reverse stock split, filing of a certificate of amendment to the company’s certificate of incorporation, and…

Continue Reading

FridayNov 01, 2019 9:18 am

NetworkNewsBreaks – SinglePoint, Inc. (SING) CEO Discusses Hemp Cigarettes on MoneyTV with Donald Baillargeon

Technology and investment company SinglePoint (OTCQB: SING) was featured on this week’s episode of MoneyTV with Donald Baillargeon. The program is syndicated internationally and covers money-focused topics, featuring various companies and in-depth interviews with CEOs and executives that offer insights into operations and future outlooks. MoneyTV is viewed in over 200 million households in more than 75 countries. This week’s program featured SinglePoint CEO Greg Lambrecht as he discussed the company’s recent endeavor into the hemp cigarette space. “This hemp cigarette business is really going to be huge,” SinglePoint CEO Greg Lambrecht stated in the interview. To view the full…

Continue Reading

ThursdayOct 31, 2019 1:25 pm

NetworkNewsBreaks – Global Fiber Technologies, Inc. (GFTX) Engages Investor Relations Firm International Monetary

Global Fiber Technologies (OTCQB: GFTX), a New Jersey-based “textile fiber” technology company, today announced that the company has retained Newport Beach, CA-based International Monetary to develop and oversee a complete investor relations program and finance initiative. “We chose International Monetary because we wanted an experienced and well-connected investor relations firm that we felt was capable of keeping up with us, ready to get out there and communicate what we believe is a company with game changing technologies and trade secrets combined with a compelling value proposition, and the ability to exemplify our commitment to building shareholder value. This is a…

Continue Reading

ThursdayOct 31, 2019 10:50 am

NetworkNewsBreaks – Trxade Group Inc. (TRXD) Achieves Record Revenues in Q3 2019

Trxade Group (OTCQB: TRXD), an integrated pharma supply chain and care platform, today announced its financial results for its third quarter ended September 30, 2019, and provided a business update. Among the highlights, the company reported the following results for quarter ending September 30, 2019 as compared to quarter ending September 30, 2018: record revenue growth of 173% to $2.311 million; operating income growth of 94% to $177,853; seventh straight quarter of positive operating income; and shareholder equity increase to $3.89 million. “During the third quarter of 2019, we made excellent progress in our core proprietary B2B trading platform www.Trxade.com,…

Continue Reading

ThursdayOct 31, 2019 10:08 am

NetworkNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Achieves First Milestone in Cancer Quest 2020 Project

Predictive Oncology (NASDAQ: POAI), focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, this morning announced that its Helomics subsidiary has begun to sequence tumor cases from its collaboration with the UPMC Magee Women’s Hospital (http://nnw.fm/4uKXL). According to the update, the Helomics and UPMC Magee partnership focuses on analyzing the genomic and drug response profiles of women with ovarian cancer to build AI-driven predictive models’ terms of therapy response. A key benchmark in Predictive Oncology’s Cancer Quest 2020 project, the collaboration takes a retrospective look at around 400 ovarian cancer cases that Helomics profiled for drug response,…

Continue Reading